DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
MDM2
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MDM2
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMG-820
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasms; Pancreatic Neoplasms
Macrophage colony stimulating factor receptor inhibitor
AMG-820
×
Maximum Phase:
1
First Approval:
None
UNII:
SZ3778HS3S
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04455242
1
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder; Depressive Disorder
Unknown
PF-04455242
×
Maximum Phase:
1
First Approval:
None
UNII:
Y3530Z78QD
Molecule Type:
Small molecule
Molecular Formula:
C21H28N2O2S
Molecular Weight:
372.53
AlogP:
3.88
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
7.0
Source:
PROFILNINE SD
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PROFILNINE SD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHANE DIMETHANE SULFONATE
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Renal Cell; Colonic Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin
Unknown
ETHANE DIMETHANE SULFONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
EW8V7BJ66Q
Molecule Type:
Small molecule
Molecular Formula:
C4H10O6S2
Molecular Weight:
218.25
AlogP:
-1.06
PSA:
86.74
HBD:
0.0
HBA:
#RotB:
5.0
Source:
TIDUTAMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
TIDUTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
88635FW2QX
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KO-539
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
KO-539
×
Maximum Phase:
1
First Approval:
None
UNII:
4MOD1F4ENC
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PATRITUMAB DERUXTECAN
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
DNA topoisomerase I inhibitor
PATRITUMAB DERUXTECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
3XPI7EG4W8
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIAPENEM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
BIAPENEM
×
Maximum Phase:
1
First Approval:
None
UNII:
YR5U3L9ZH1
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O4S
Molecular Weight:
350.4
AlogP:
-1.89
PSA:
102.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NG-NITRO-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NG-NITRO-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
TNB-486
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TNB-486
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFINEPTAKIN ALFA
1
Protein
Investigational
Unknown
Unknown
Leukoencephalopathy, Progressive Multifocal; Severe Acute Respiratory Syndrome
Unknown
EFINEPTAKIN ALFA
×
Maximum Phase:
1
First Approval:
None
UNII:
3K3WC6MT6P
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
GSK-923295A
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
GSK-923295A
×
Maximum Phase:
1
First Approval:
None
UNII:
072702W9QD
Molecule Type:
Small molecule
Molecular Formula:
C32H38ClN5O4
Molecular Weight:
592.14
AlogP:
4.51
PSA:
108.2
HBD:
3.0
HBA:
#RotB:
12.0
Source:
GI HEPTAPEPTIDE
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
GI HEPTAPEPTIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
D33CAJ796A
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
E-2212
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
E-2212
×
Maximum Phase:
1
First Approval:
None
UNII:
V9KGF25853
Molecule Type:
Small molecule
Molecular Formula:
C25H23F3N6O
Molecular Weight:
480.49
AlogP:
5.29
PSA:
70.65
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PF-05180999
1
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders; Schizophrenia
Unknown
PF-05180999
×
Maximum Phase:
1
First Approval:
None
UNII:
5L84K4IEN9
Molecule Type:
Small molecule
Molecular Formula:
C19H17F3N8
Molecular Weight:
414.4
AlogP:
3.12
PSA:
77.03
HBD:
0.0
HBA:
#RotB:
3.0
Source:
OXYNTOMODULIN
1
Protein
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Obesity
Unknown
OXYNTOMODULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
C192H295N59O60S
Molecular Weight:
4421.89
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
QUEMLICLUSTAT
1
Small molecule
Investigational
Unknown
Unknown
Pancreatic Neoplasms; Prostatic Neoplasms
Unknown
QUEMLICLUSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
J6K8WSV73A
Molecule Type:
Small molecule
Molecular Formula:
C20H24ClFN4O9P2
Molecular Weight:
580.83
AlogP:
2.35
PSA:
196.49
HBD:
6.0
HBA:
#RotB:
9.0
Source:
LODAPOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Neoplasms; Pancreatic Neoplasms
Unknown
LODAPOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
NR4MAD6PPB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMC-EB10
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid
Tyrosine-protein kinase receptor FLT3 inhibitor
IMC-EB10
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IDEC-159 90Y
1
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Tumor-associated antigen 72 binding agent
IDEC-159 90Y
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULTHIAME
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Carbonic anhydrase inhibitor
SULTHIAME
×
Maximum Phase:
1
First Approval:
None
UNII:
I00Q766CZ2
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4S2
Molecular Weight:
290.37
AlogP:
0.26
PSA:
97.54
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BORNEOL
1
Small molecule
Investigational
Unknown
Unknown
Angina, Stable
Unknown
BORNEOL
×
Maximum Phase:
1
First Approval:
None
UNII:
M89NIB437X
Molecule Type:
Small molecule
Molecular Formula:
C10H18O
Molecular Weight:
154.25
AlogP:
2.19
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ACHN-975
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACHN-975
×
Maximum Phase:
1
First Approval:
None
UNII:
48CET2EN53
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O4
Molecular Weight:
369.42
AlogP:
0.01
PSA:
124.68
HBD:
5.0
HBA:
#RotB:
5.0
Source:
ATIPAMEZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ATIPAMEZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
03N9U5JAF6
Molecule Type:
Small molecule
Molecular Formula:
C14H16N2
Molecular Weight:
212.3
AlogP:
2.86
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LETRAZURIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LETRAZURIL
×
Maximum Phase:
1
First Approval:
None
UNII:
U8736VCB22
Molecule Type:
Small molecule
Molecular Formula:
C17H9Cl2FN4O2
Molecular Weight:
391.19
AlogP:
3.02
PSA:
91.54
HBD:
1.0
HBA:
#RotB:
3.0
Source:
AZD2461
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
AZD2461
×
Maximum Phase:
1
First Approval:
None
UNII:
3K288XF5XJ
Molecule Type:
Small molecule
Molecular Formula:
C22H22FN3O3
Molecular Weight:
395.43
AlogP:
2.9
PSA:
75.29
HBD:
1.0
HBA:
#RotB:
4.0
Source:
2-DEOXYGLUCOSE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
2-DEOXYGLUCOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MTI-31
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
MTI-31
×
Maximum Phase:
1
First Approval:
None
UNII:
RM15YYQ1CI
Molecule Type:
Small molecule
Molecular Formula:
C26H30N6O3
Molecular Weight:
474.57
AlogP:
2.64
PSA:
92.71
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TALINOLOL
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Obesity, Morbid
Unknown
TALINOLOL
×
Maximum Phase:
1
First Approval:
None
UNII:
3S82268BKG
Molecule Type:
Small molecule
Molecular Formula:
C20H33N3O3
Molecular Weight:
363.5
AlogP:
3.27
PSA:
82.62
HBD:
4.0
HBA:
#RotB:
7.0
Source:
PF-06747143
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
PF-06747143
×
Maximum Phase:
1
First Approval:
None
UNII:
7TS9C20ZWA
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
1
2
…
98
99
100
101
102
103
104
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA